59 related articles for article (PubMed ID: 27987344)
1. Three-dimensional evaluation of lipiodol retention in HCC after chemoembolization: a quantitative comparison between CBCT and MDCT.
Wang Z; Lin M; Lesage D; Chen R; Chapiro J; Gu T; Tacher V; Duran R; Geschwind JF
Acad Radiol; 2014 Mar; 21(3):393-9. PubMed ID: 24507426
[TBL] [Abstract][Full Text] [Related]
2. Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.
Salem R; Gordon AC; Mouli S; Hickey R; Kallini J; Gabr A; Mulcahy MF; Baker T; Abecassis M; Miller FH; Yaghmai V; Sato K; Desai K; Thornburg B; Benson AB; Rademaker A; Ganger D; Kulik L; Lewandowski RJ
Gastroenterology; 2016 Dec; 151(6):1155-1163.e2. PubMed ID: 27575820
[TBL] [Abstract][Full Text] [Related]
3. Controlling Nutritional Status (CONUT) Score is Associated with Overall Survival in Patients with Hepatocellular Carcinoma Treated with Conventional Transcatheter Arterial Chemoembolization: A Propensity Score Matched Analysis.
Deng Z; Zhang W; Peng J; Gao L; Zhang C; Lei K; Gong J; Xiong B
Cardiovasc Intervent Radiol; 2024 May; 47(5):592-603. PubMed ID: 38605220
[TBL] [Abstract][Full Text] [Related]
4. Lipiodol as a Predictive Indicator for Therapy Response to Transarterial Chemoembolization of Hepatocellular Carcinoma.
Langenbach MC; Vogl TJ; Said G; Scholtz JE; Hammerstingl R; Gruber-Rouh T
Cancer Biother Radiopharm; 2024 Apr; 39(3):196-202. PubMed ID: 33481646
[No Abstract] [Full Text] [Related]
5. Prognostic significance of serum procalcitonin in patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization: A retrospective analysis of 509 cases.
Shen H; Zheng S; Chen R; Jin X; Xu X; Jing C; Lin J; Zhang J; Zhang M; Zhang L; Xie X; Guo K; Ren Z; Lin S; Zhang B
Medicine (Baltimore); 2017 Jul; 96(28):e7438. PubMed ID: 28700480
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive assessment of response to transcatheter arterial chemoembolization for hepatocellular carcinoma with the deep neural networks-based radiomics nomogram.
Liu Y; Liu Z; Li X; Zhou W; Lin L; Chen X
Acta Radiol; 2024 Jun; 65(6):535-545. PubMed ID: 38489805
[TBL] [Abstract][Full Text] [Related]
7. Transcatheter arterial chemoembolization plus atezolizumab and bevacizumab for unresectable hepatocellular carcinoma: a single-arm, phase II trial.
Wang K; Yu HM; Xiang YJ; Cheng YQ; Ni QZ; Guo WX; Shi J; Feng S; Zhai J; Cheng SQ
Future Oncol; 2022 Sep; 18(30):3367-3375. PubMed ID: 35968836
[TBL] [Abstract][Full Text] [Related]
8. Successful Endovascular Management of Pseudoaneurysm following Transarterial Chemoembolization: A Case Report.
Jang JY; Kim TU; Ryu H; Yoon KT; Hong YM; Jeon UB
Medicina (Kaunas); 2024 Apr; 60(5):. PubMed ID: 38792887
[No Abstract] [Full Text] [Related]
9. Ethiodized oil as an imaging biomarker after conventional transarterial chemoembolization.
Mendiratta-Lala M; Aslam A; Bai HX; Chapiro J; De Baere T; Miyayama S; Chernyak V; Matsui O; Vilgrain V; Fidelman N
Eur Radiol; 2024 May; 34(5):3284-3297. PubMed ID: 37930412
[TBL] [Abstract][Full Text] [Related]
10. Impact of iodinated oil in proton therapy on relative stopping power of liver post-cTACE.
Shu J; Zhang J; Jee K; Liu L; Hu M; Huo W; Cui X; Wang H; Lu HM
Phys Med Biol; 2024 Apr; 69(9):. PubMed ID: 38537311
[No Abstract] [Full Text] [Related]
11. Transarterial chemoembolization for hepatocellular carcinoma: 2023 expert consensus-based practical recommendations of the Korean Liver Cancer Association.
Cho Y; Choi JW; Kwon H; Kim KY; Lee BC; Chu HH; Lee DH; Lee HA; Kim GM; Oh JS; Hyun D; Lee IJ; Rhim H;
J Liver Cancer; 2023 Sep; 23(2):241-261. PubMed ID: 37449302
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Transarterial Chemoembolization with a Three-Stage Mixed Chemoembolic Regimen for Large Unresectable Hepatocellular Carcinoma.
Yang Y; Du N; Ma J; Peng Z; Zhou B; Yu J; Zhou X; Zhang W; Yan Z
J Hepatocell Carcinoma; 2023; 10():1897-1910. PubMed ID: 37904836
[TBL] [Abstract][Full Text] [Related]
13. The Expression and Function of Circadian Rhythm Genes in Hepatocellular Carcinoma.
Jiang Y; Shen X; Fasae MB; Zhi F; Chai L; Ou Y; Feng H; Liu S; Liu Y; Yang S
Oxid Med Cell Longev; 2021; 2021():4044606. PubMed ID: 34697563
[TBL] [Abstract][Full Text] [Related]
14. Outcome of TACE treatment in HIV infected patients with hepatocellular carcinoma.
Kong L; Wei G; Lv T; Jiang L; Yang J; Zhao Y; Yang J
Sci Rep; 2021 Jan; 11(1):696. PubMed ID: 33436856
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Transarterial Chemoembolization in Combination With Kang'ai Injection on Patients With Intermediate Stage Hepatocellular Carcinoma: A Prospective Study.
Wan YM; Li YH; Xu ZY; Wu HM; Xu Y; Yang M; Wu XN
Integr Cancer Ther; 2018 Jun; 17(2):477-485. PubMed ID: 29108428
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of transcatheter arterial chemoembolization with embospheres in treatment of hepatocellular carcinoma.
Hao MZ; Lin HL; Chen QZ; Hu YB; Chen JB; Zheng JX; Zhou D; Zhang H
J Dig Dis; 2017 Jan; 18(1):31-39. PubMed ID: 27987344
[TBL] [Abstract][Full Text] [Related]
17. Imaging Changes and Clinical Complications After Drug-Eluting Bead Versus Conventional Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Multicenter Study.
Zhang L; Sun JH; Ji JS; Zhong BY; Zhou GH; Song JJ; Hou ZH; Huang P; Zhang S; Li Z; Zhu XL; Ni CF
AJR Am J Roentgenol; 2021 Oct; 217(4):933-943. PubMed ID: 33245680
[No Abstract] [Full Text] [Related]
18. Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
Liu YS; Lin CY; Chuang MT; Lin CY; Tsai YS; Wang CK; Ou MC
BMC Gastroenterol; 2018 Aug; 18(1):124. PubMed ID: 30075752
[TBL] [Abstract][Full Text] [Related]
19. CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study.
Wu B; Zhou J; Ling G; Zhu D; Long Q
World J Surg Oncol; 2018 Mar; 16(1):69. PubMed ID: 29587773
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]